Back to Search Start Over

Pancreatic cyst fluid harboring a KRAS mutation.

Authors :
Al-Turkmani MR
Gordon SR
Smith KD
Tsongalis GJ
Liu X
Source :
Cold Spring Harbor molecular case studies [Cold Spring Harb Mol Case Stud] 2019 Apr 01; Vol. 5 (2). Date of Electronic Publication: 2019 Apr 01 (Print Publication: 2019).
Publication Year :
2019

Abstract

A 55-yr-old woman presented with abdominal bloating for approximately 1 year. Imaging studies showed a cyst in the body of the pancreas with proximal pancreatic ductal dilation. An endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) was performed. Cytologic findings from the cyst fluid were consistent with a mucinous neoplastic cyst, and the possibility of malignancy could not be entirely excluded. A KRAS mutation analysis was performed on the cyst fluid using the Idylla system and circulating tumor KRAS (ctKRAS) cartridge (Biocartis, Mechelen, Belgium), which tests for actionable mutations in exons 2, 3, and 4 of the KRAS gene. Idylla testing detected a KRAS G12D mutation in the cyst fluid. The patient subsequently underwent a distal subtotal pancreatectomy with splenectomy. Microscopic examination of the resected tissue revealed an intraductal papillary mucinous neoplasm (IPMN) with an associated invasive carcinoma. KRAS testing on the resected tumor tissue confirmed the G12D mutation detected in the cyst fluid earlier. The described rapid testing of KRAS directly from the pancreatic cyst fluid can complement cytology assessment to classify pancreatic cysts more reliably and can potentially be of significant help when other cyst findings are nondiagnostic.<br /> (© 2019 Al-Turkmani et al.; Published by Cold Spring Harbor Laboratory Press.)

Details

Language :
English
ISSN :
2373-2873
Volume :
5
Issue :
2
Database :
MEDLINE
Journal :
Cold Spring Harbor molecular case studies
Publication Type :
Academic Journal
Accession number :
30936197
Full Text :
https://doi.org/10.1101/mcs.a003830